Medication-overuse headache is one of the most disabling headaches. Antiepileptic drugs have been considered a promising strategy as prophylactic treatment in these patients, even if their use often has been limited by low tolerability or safety. The objective of this study was to evaluate the efficacy and safety of pregabalin compared with topiramate for the prophylaxis of chronic daily headache with medication overuse using an open-label prospective study.

Rizzato, B., Leone, G., Misaggi, G., Zivi, I., Diomedi, M. (2011). Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study. CLINICAL NEUROPHARMACOLOGY, 34(2), 74-78 [10.1097/WNF.0b013e318210ecc9].

Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study

DIOMEDI, MARINA
2011-01-01

Abstract

Medication-overuse headache is one of the most disabling headaches. Antiepileptic drugs have been considered a promising strategy as prophylactic treatment in these patients, even if their use often has been limited by low tolerability or safety. The objective of this study was to evaluate the efficacy and safety of pregabalin compared with topiramate for the prophylaxis of chronic daily headache with medication overuse using an open-label prospective study.
2011
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/26 - NEUROLOGIA
English
Con Impact Factor ISI
Treatment Outcome; Male; Time Factors; Young Adult; Middle Aged; Female; Chi-Square Distribution; Disability Evaluation; Headache Disorders, Secondary; Humans; Prospective Studies; Follow-Up Studies; Anticonvulsants; Fructose; Pain Measurement; Aged; Headache Disorders; Adult; gamma-Aminobutyric Acid
Rizzato, B., Leone, G., Misaggi, G., Zivi, I., Diomedi, M. (2011). Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study. CLINICAL NEUROPHARMACOLOGY, 34(2), 74-78 [10.1097/WNF.0b013e318210ecc9].
Rizzato, B; Leone, G; Misaggi, G; Zivi, I; Diomedi, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Efficacy_and_Tolerability_of_Pregabalin.pdf

solo utenti autorizzati

Licenza: Copyright dell'editore
Dimensione 133.67 kB
Formato Adobe PDF
133.67 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/51215
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 12
social impact